JOYCE TSAI
Medical Practice in New York, NY
License number
New Jersey 25MA10028700
Issued Date
Oct 2, 2017
Expiration Date
Jun 30, 2017
Category
Medical Examiners
Type
Medical Doctor
Address
Address
New York, NY
Personal information
See more information about JOYCE TSAI at radaris.comName
Address
Phone
360 Cabrini Blvd APT 2N, New York, NY 10040
518 Higby Rd, New Hartford, NY 13413
360 Cabrini Blvd #2 N, New York, NY 10040
700 Fort Washington Ave, New York, NY 10040
500 63Rd St, New York, NY 10021
Professional information
See more information about JOYCE TSAI at trustoria.com
Methods Of Treating Central Nervous System Disorders With A Low Dose Combination Of Escitalopram And Bupropion
Methods Of Treating Central Nervous System Disorders With A Low Dose Combination Of Escitalopram And Bupropion
US Patent:
2007020, Aug 30, 2007
Filed:
Oct 16, 2006
Appl. No.:
11/549714
Inventors:
Jeffrey Jonas - Hoboken NJ, US
Anjana Bose - Roseland NJ, US
Joyce Tsai - New York NY, US
Anjana Bose - Roseland NJ, US
Joyce Tsai - New York NY, US
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K 31/343, A61K 31/195
US Classification:
514469000, 514563000
Abstract:
The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.
Methods Of Treating Central Nervous System Disorders With A Low Dose Combination Of Escitalopram And Bupropion
Methods Of Treating Central Nervous System Disorders With A Low Dose Combination Of Escitalopram And Bupropion
US Patent:
2009026, Oct 22, 2009
Filed:
Jun 23, 2009
Appl. No.:
12/489891
Inventors:
Jeffrey Jonas - Hoboken NJ, US
Anjana Bose - Roseland NJ, US
Joyce Tsai - New York NY, US
Anjana Bose - Roseland NJ, US
Joyce Tsai - New York NY, US
Assignee:
Forest Laboratories Holdings Limited - Hammilton
International Classification:
A61K 31/343
US Classification:
514469
Abstract:
The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.